Decorative curls

Media

Follow along on our journey

The TELUS venture investment arm (TELUS Pollinator Fund for Good) and Spring Activator organized a Canada-wide healthcare challenge. UVX was selected as Top 20 in February 2022, and then moved on to Top 10, and then ultimately to Top 5. A cohort of 35 investors then conducted due diligence on the Top 5 companies over 6-weeks, ultimately determining UVX to be Canada's most impactful and investable healthcare startup.

TELUS and Spring Activator determine UVX to be Canada's most impactful and investable healthcare venture

The TELUS venture investment arm (TELUS Pollinator Fund for Good) and Spring Activator organized a Canada-wide healthcare challenge. UVX was selected as Top 20 in February 2022, and then moved on to Top 10, and then ultimately to Top 5. A cohort of 35 investors then conducted due diligence on the Top 5 companies over 6-weeks, ultimately determining UVX to be Canada's most impactful and investable healthcare startup.

June 8, 2022
https://www.linkedin.com/posts/spring-is_pollinatorfund-impactinvesting-impactentrepreneurship-activity-6940710683990773760-ayjq/
New Ventures BC is British Columbia’s largest (and most selective) industry-agnostic startup competition, with a panel of 95 judges from various industries. Over the coming months, UVX and a bunch of other great startups will be competing to win $250,000 in cash and prizes.

UVX is Top 15 in New Ventures BC Competition

New Ventures BC is British Columbia’s largest (and most selective) industry-agnostic startup competition, with a panel of 95 judges from various industries. Over the coming months, UVX and a bunch of other great startups will be competing to win $250,000 in cash and prizes.

June 6, 2022
https://www.newventuresbc.com/2022/06/2022-competition-round-2-5-and-round-3-announcement/
After months of evaluating amazing healthcare ventures, the TELUS venture investment arm (TELUS Pollinator Fund for Good) and Spring Activator select UVX as a Top 20 healthcare company Canada-wide.

TELUS and Spring Activator select UVX as Top 20 healthcare venture Canada-wide

After months of evaluating amazing healthcare ventures, the TELUS venture investment arm (TELUS Pollinator Fund for Good) and Spring Activator select UVX as a Top 20 healthcare company Canada-wide.

February 22, 2022
https://spring.is/programs/impact-investor-challenge/meet-the-top-20-startups-health-impact-investor-challenge/
UVX co-founders Saimir and Kunal demonstrated Zener, UVX's first product, at University of British Columbia's e@UBC Venture Showcase. In the category that UVX was presenting, UVX placed 2nd for People's Choice Award.

UVX demonstrates Zener at UBC's Venture Showcase and places 2nd in a category for People's Choice Award

UVX co-founders Saimir and Kunal demonstrated Zener, UVX's first product, at University of British Columbia's e@UBC Venture Showcase. In the category that UVX was presenting, UVX placed 2nd for People's Choice Award.

November 24, 2021
https://www.linkedin.com/feed/update/urn:li:activity:6869704931344023552/
UVX is excited to announce that the Division of Infectious Diseases, within the Faculty of Medicine at the University of British Columbia (UBC), has commenced testing of UVX’s core technology: filtered 222nm Far-UVC light produced by UVX’s flagship Zener device. The tests will be conducted at the Jack Bell Research Centre.

UBC’s Faculty of Medicine starts testing UVX’s human-safe ultra-violet technology

UVX is excited to announce that the Division of Infectious Diseases, within the Faculty of Medicine at the University of British Columbia (UBC), has commenced testing of UVX’s core technology: filtered 222nm Far-UVC light produced by UVX’s flagship Zener device. The tests will be conducted at the Jack Bell Research Centre.

September 1, 2021
The negative socio-economic effects of infectious diseases are undeniable. Yet traditional chemical disinfectants and UV solutions fail to effectively and efficiently mitigate these issues. Recognizing the shortcomings of traditional methods, UVX makes disinfection effortless, affordable, effective, sustainable, and safe for everyone.

UVX featured as "Startup of the Week", a highlight of British Columbia's most innovative and exiting startups

The negative socio-economic effects of infectious diseases are undeniable. Yet traditional chemical disinfectants and UV solutions fail to effectively and efficiently mitigate these issues. Recognizing the shortcomings of traditional methods, UVX makes disinfection effortless, affordable, effective, sustainable, and safe for everyone.

August 13, 2021
https://techcouver.com/2021/08/13/startup-of-the-week-uvx/
Engineer Kunal Sethi is secretive about what, exactly, his revolutionary germ-zapper will look like. But it will be small, he says: a programmable, ceiling-mounted device roughly the size of a Wi-Fi router that quietly bathes entire rooms in ultraviolet light — potentially saving tens of thousands of lives each year.

UVX Co-founder, Kunal, is recognized as a Changemaker by the University of British Columbia

Engineer Kunal Sethi is secretive about what, exactly, his revolutionary germ-zapper will look like. But it will be small, he says: a programmable, ceiling-mounted device roughly the size of a Wi-Fi router that quietly bathes entire rooms in ultraviolet light — potentially saving tens of thousands of lives each year.

June 23, 2021
https://trekmagazine.alumni.ubc.ca/2021/spring-2021/changemakers/health-technology/life-saving-light
Discover the Canadian healthtech start-ups to watch in 2021. MEDTEQ+, through its AIM coaching program, has selected about twenty promising companies in health technologies.

MEDTEQ+ names UVX as a Canadian healthtech startup to watch in 2021

Discover the Canadian healthtech start-ups to watch in 2021. MEDTEQ+, through its AIM coaching program, has selected about twenty promising companies in health technologies.

March 3, 2021
https://www.medteq.ca/en/canadian-healthtech-start-ups-to-watch-in-2021/?utm_source=linkedin&utm_medium=social&utm_campaign=AIM